Literature DB >> 2521932

B1 variant of GM2 gangliosidosis in a 12-year-old patient.

H H Goebel1, G Stolte, B Kustermann-Kuhn, K Harzer.   

Abstract

A girl aged 12 y, 9 mo, suffered from a progressive neurodegenerative disorder marked by ataxia, extrapyramidal symptoms, and convulsions. A skin biopsy showed axonal pathology that emphasized axonal segments enlarged by mitochondria, dense bodies, and lysosomal residual bodies of the membranous cytoplasmic body type. This ultrastructural pathology suggested GM2 gangliosidosis which was shown to be a B1 variant by specific biochemical studies, although conventional techniques had failed to detect GM2 gangliosidosis. The B1 variant is marked by a deficient activity of beta-hexosaminidase A towards one substrate, and by an almost normal activity towards another. Both parents showed a diminished activity towards the sulfated substrate, suggesting a heterozygous state, and almost normal activity with the second substrate type.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521932     DOI: 10.1203/00006450-198901000-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Unusual presentation of GM2 gangliosidosis mimicking a brain stem tumor in a 3-year-old girl.

Authors:  Marie-Cécile Nassogne; Marie-Christine Commare; Arielle Lellouch-Tubiana; Sophie Emond; Michel Zerah; Catherine Caillaud; Lucie Hertz-Pannier; Jean-Marie Saudubray
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Biochemical characterization of beta-hexosaminidase in different biological specimens from eleven patients with GM2-gangliosidosis B1 variant.

Authors:  M G Ribeiro; R A Pinto; M R Dos Santos; M Maia; M C Sá Miranda
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  A case of the B1 variant of GM2-gangliosidosis.

Authors:  R G Gray; A Green; L Rabb; D M Broadhead; G T Besley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 4.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

5.  Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.

Authors:  B Schmid; B C Paton; K Sandhoff; K Harzer
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.